Mamata’s appointee to STM lands herself in ethical row
- One needs to be a good listener to become a good orator: PM Modi
- Migrant crisis: Father of drowned Syrian toddler returns to Kobani for burial
- IIT graduate who fled with Harley Davidson held in Mumbai
- Delhi HC allows permanent commission for women in Indian Navy
- Hindu group forces Muslim writer in Kerala to stop Ramayana column
Nandita Bose, whose appointment as the new director of School of Tropical Medicine (STM) was approved by Chief Minister Mamata Banerjee a week ago, has landed herself in controversy even before taking charge of the post.
Bose signed the treatment sheets of two patients undergoing stem cell therapy at the STM on August 3 violating the rules of the Medical Council of India as doctors can only sign the treatment sheet of patients where they are officially appointed. Till date, Bose is the head of the pathology department at Midnapore Medical College and Hospital. As a result, she cannot sign treatment sheets of patients admitted to the STM. As per the rules, Niranjan Bhattacharya, who is the head of the regenerative medicine can only sign treatment sheets for the STM patients. Before any stem cell therapy is being conducted,it should get approval from the director or the ethical committee that has been formed to monitor the works of the regenerative medicine department.
The incumbent director of the STM, Krishnanghsu Roy, has termed Bose's action unethical. "We have informed the matter to the director of medical education in this regard," he added.
Director of Medical Education Susanta Banerjee, however, did not confirm whether he has received any complaint or not, and said: "I will inform the matter to the concerned person."
Bose, meanwhile, justified her action saying she signed the treatment sheets as she will be doing PhD in regenerative medicine from the STM after becoming the director. "I am not aware of any medico-legal issues in the case," she added.
No research in tropical medicines, Nandita Bose gets top job at STM